Cycle and Pregnancy Monitoring With Wearable Sensor Technology (AVA)
NCT ID: NCT03161873
Last Updated: 2022-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
194 participants
OBSERVATIONAL
2016-11-30
2020-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
All pregnancies beginning during the study period are to be monitored to their natural end, in order to evaluate how the same nine physiological parameters are changing during pregnancy, how strong the variations of the parameters during pregnancy are, and whether they could be associated with early onsets of pregnancy complications such as premature birth or pre-eclampsia. This will be highly valuable to develop study protocols for the specific evaluation of the screening potential of pregnancy complications.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sensor Technology Assessments of Reproductive Target Study
NCT06142097
Smartphone vs Manual Interpretation of Biomarkers for Ovulation and Luteal Phase Detection (SMOM Study)
NCT07248046
Evaluation of Pharmacodynamic Effects on Ovulation and Cycle Control
NCT01250210
Menstrual Cycle Symptom Tracking
NCT04756739
Effects of Gynecological Age on LH Sensitivity to Energy Availability
NCT00260286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
avaOnly
Participants will measure with Ava bracelet and determine ovulation with a home (luteinizing hormone) LH urine test
Ava
Ava is a fertility monitoring bracelet that collects various physiological parameters
avaSaliva
Participants will measure with Ava bracelet and determine ovulation with a home LH urine test. In addition participants will collect saliva for the measurements of estrogen and progesterone.
Ava
Ava is a fertility monitoring bracelet that collects various physiological parameters
avaSalivaUS
Participants will measure with Ava bracelet and determine ovulation with a home LH urine test. In addition participants will collect saliva for the measurements of estrogen and progesterone. Moreover ultrasound will be used to observe the day at which the ovum is released.
Ava
Ava is a fertility monitoring bracelet that collects various physiological parameters
avaBBT
Participants will measure with Ava bracelet and determine ovulation with a home LH urine test. In addition, participants will measure their basal body temperature (BBT) daily.
Ava
Ava is a fertility monitoring bracelet that collects various physiological parameters
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ava
Ava is a fertility monitoring bracelet that collects various physiological parameters
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* regular menstrual cycle (28 days+/-)
* no hormonal therapy
* German-speaking
* written informed consent to participate in the study
Exclusion Criteria
* any consumption of medication or other substances that may affect the menstrual cycle or any of the physiological parameters investigated
* frequent travel between time zones
* sleeping disorders
* unsuccessfully trying to conceive for \> 12 months
20 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ava AG
INDUSTRY
CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Developpement
INDUSTRY
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brigitte Leeners, Prof
Role: PRINCIPAL_INVESTIGATOR
University of Zurich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinic for Reproductive Endocrinology
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S_US_Ava
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.